DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
” - 2 “ It’s - 2 “ - 2 Walter Willett - 1 Harvard T.H - 1 ” Willett - 1 Tamara Hannon - 1 “ There’s - 1
Top related locs:
Chan Boston Indianapolis China Bethesda , Maryland Ziwawo United States Atlanta
Top related orgs:
Indiana University School of Medicine - 3 CNN - 2 FDA - 2 Harvard - 1 of Public Health - 1 Harvard Medical School - 1 American Academy of Pediatrics - 1 AAP - 1

Search resuls for: "Indiana University School of Medicine"


5 mentions found


☆ Weight gain in children and adults linked to 100% fruit juice, study says
  + stars: | 2024-01-16 | by ( Sandee Lamotte | ) edition.cnn.com   time to read: +7 min
CNN —Drinking a glass or more of 100% fruit juice each day was linked to a small increase in weight in children and adults, according to a new analysis of prior studies. In such a context, fruit juice is a much better choice than soda, for many reasons,” said Katz in an email. How juice impacts the bodyFor some, the concern over 100% fruit juice may be baffling — fruit is healthy, right? Eating a whole apple, for example, doesn’t spike blood sugar levels because fructose, the sugar found naturally in fruits and some vegetables, is released slowly into the blood. In children, each additional serving per day of 100% fruit juice was associated with a 0.03 higher body mass index, or BMI, change, according to the study.
Persons: ”, Walter Willett, Harvard T.H, ” Willett, Tamara Hannon, “ There’s, Hannon, David Katz, “ It’s, Katz, Britt Erlanson, ” Hannon, ” That’s, Vasanti Malik, ” Malik, Malik, “ Organizations: CNN, Harvard, of Public Health, Harvard Medical School, American Academy of Pediatrics, AAP, Riley Hospital for Children, Indiana University School of Medicine, True Health, True Health Initiative, Bank, Getty, BMI, CDC Locations: Chan, Boston, Indianapolis
☆ Meet the Black students who were instrumental in developing the first Covid-19 shots
  + stars: | 2023-09-15 | by ( Jacqueline Howard | ) edition.cnn.com   time to read: +10 min
Among about two dozen scientists in Graham’s lab were three young students: Olubukola Abiona, Geoffrey Hutchinson and Cynthia Ziwawo. What the world didn’t know at the time was that those three students — Abiona, Hutchinson and Ziwawo — were doing the foundational work for those vaccines to eventually save lives. Geoffrey Hutchinson served in the Peace Corps and taught chemistry to high school students in Mozambique. The fruits of Abiona, Hutchinson and Ziwawo’s labor were evident this week as the United States began to roll out updated versions of the Moderna and Pfizer/BioNTech Covid-19 vaccines. Abiona, Hutchinson and Ziwawo all confirmed Wednesday that although they haven’t made their appointments yet, they plan to get the updated shots.
Persons: Barney Graham’s, Olubukola Abiona, Geoffrey Hutchinson, Cynthia Ziwawo, “, Graham, ‘, ’ ”, Hutchinson, ”, ” Ziwawo, Anthony Fauci, — Abiona, Ziwawo —, Ziwawo, Kizzmekia Corbett, ” Corbett, David Satcher, he’s, Valerie Montgomery Rice, “ They’re, Abiona, Hannah Montana, Austin Steele, CNN Abiona, BioNTech, “ It’s, Dr, Sanjay Gupta Organizations: CNN, Vaccine Research, National Institutes of Health, University of Washington, “, Vaccine Research Center, National Institute of Allergy, Diseases, Moderna, Morehouse School of Medicine, David Satcher Global Health Equity Institute, Association of American Medical Colleges, NIH, Disney, David Satcher Global Health Equity Summit, KPMG LLP, Indiana University School of Medicine, Case Western Reserve University, Peace Corps, United States, Pfizer, CNN Health, FDA, Food and Drug Administration, US Centers for Disease Control Locations: China, Bethesda , Maryland, Ziwawo, United States, Atlanta, Graham’s, Nigeria, Mozambique, Abiona, United
☆ Lilly drug slows Alzheimer's by 60% for mildly impaired patients in trial
  + stars: | 2023-07-17 | by ( Deena Beasley | ) www.reuters.com   time to read: +5 min
Lilly expects the U.S. Food and Drug Administration to decide by the end of this year whether to approve donanemab. The company had previously reported that 24% of the overall donanemab treatment group had brain swelling. The deaths of three trial patients were linked to the treatment, researchers reported. For high tau patients, donanemab was shown to slow disease progression by about 17%, while the benefit was 35% for those with low-to-intermediate tau levels. Both medications are also being studied in large trials to see if they have an impact on delaying onset of Alzheimer's disease symptoms.
Persons: Seth Gale, Brian Snyder, Eli Lilly, Anne White, Lilly, Susan Kohlhaas, Liana Apostolova, White, Liz Coulthard, donanemab, Deena Beasley, Ludwig Burger, Will Dunham, Bill Berkrot, Caroline Humer Organizations: Alzheimer Research, Brigham, Women’s, REUTERS, Alzheimer's Association International, U.S . Food, Drug Administration, Alzheimer’s Research, Indiana University School of Medicine, Doctors, University of Bristol, JAMA, FDA, Alzheimer's Association, Health Organization, New York Stock Exchange, Thomson Locations: Boston , Massachusetts, U.S, Amsterdam, Eisai
☆ FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
  + stars: | 2023-03-22 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +3 min
The Food and Drug Administration's independent panel of advisors on Wednesday declined to endorse accelerated approval of Biogen's investigational ALS drug for a rare and aggressive form of the disease. The drug tofersen was developed to treat a rare genetic form of amyotrophic lateral sclerosis, or ALS. That number is even smaller in the U.S., with roughly 330 people affected by the SOD1 mutation. The median survival time from diagnosis with the rare form of ALS to death is 2.7 years, according to the company. The SOD1 mutation is associated with 20% of cases that occur within families.
☆ FDA advisors vote against effectiveness of Biogen's ALS drug for rare and aggressive form of the disease
  + stars: | 2023-03-22 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +3 min
The Food and Drug Administration's independent panel of advisors on Wednesday voted against the effectiveness of Biogen's investigational ALS drug for a rare and aggressive form of the disease. The drug tofersen was developed to treat a rare genetic form of amyotrophic lateral sclerosis, or ALS. That number is even smaller in the U.S., with roughly 330 people affected by the SOD1 mutation. The median survival time from diagnosis with the rare form of ALS to death is 2.7 years, according to the company. The SOD1 mutation is associated with 20% of cases that occur within families.
0 next >>
Total: 5